argenx SE (ARGX) News & Events

$1,031.660

+8.563 (+0.83%)At close

ARGX News

argenx Management to Attend Investor Conferences in September

Latest Ratings and Outlook from Wall Street

Argenx Achieves Phase 3 Success for Vyvgart Hytrulo in Autoimmune Myositis

Argenx's Vyvgart Hytrulo Shows Positive Phase 3 Results for Autoimmune Myositis

Biotech Stocks Reach 52-Week Highs Amid Positive Trials

Zai Lab and argenx Announce Positive ALKIVIA Study Results

argenx SE's ALKIVIA Trial Achieves Primary Endpoint Success

argenx ALKIVIA Study Achieves Positive Results

Halozyme Reports Increased Net Income in Q2

Investors Increase Exposure to International Equities

8/17 12:30

Argenx Shares Rise 16.6%

Argenx is up 16.6%, or…

8/17 10:30

Argenx Shares Rise 14.9%

Argenx is up 14.9%, or…

8/17 06:30

Zai Lab Partners with argenx for Strategic Collaboration

Zai Lab (ZLAB) and argenx…

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.